An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics. uri icon

authors

  • Anderson, Peter L
  • Brooks, Kristina M
  • Kristine Erlandson, MD
  • Corley, Michael J
  • Pang, Alina Ps
  • Coyle, Ryan P
  • Schlachetzki, Johannes
  • Molina, Anthony J A
  • Bushman, Lane
  • Aguado, Julio
  • Hill, Blake
  • Liu, Albert Y

publication date

  • March 26, 2026